UPDATE 1-Supernus beats Allergan over epilepsy drug patents

Feb 5 (Reuters) - A federal judge on Friday said Allergan Plc's planned generic version of a drug meant to treat epilepsy infringed patents belonging to Supernus Pharmaceuticals Inc.